Dose-Response Relationship between Post-Progression Bevacizumab Exposure and Survival among Metastatic Colorectal Cancer Patients

被引：0
|
作者：
Flick, E. Dawn [1 ]
Barr, Charles E. [1 ]
Fish, Susan M. [1 ]
Leon, Larry F. [1 ]
Mun, Yong [1 ]
Dalal, Darshan [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
520
引用
收藏
页码：244 / 245
页数：2
相关论文
共 50 条
  • [21] Post-progression therapy (PPT) effect on survival in AVF2107, a phase III trial of bevacizumab in first-line treatment of metastatic colorectal cancer (mCRC).
    Hedrick, EE
    Hurwitz, H
    Sarkar, S
    Griffing, S
    Novotny, W
    Grothey, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 249S - 249S
  • [22] Treatment beyond progression in metastatic colorectal cancer: to double or not to double the dose of bevacizumab?
    Bochis, Ovidiu-Vasile
    Vlad, Catalin
    Cainap, Calin
    Achimas-Cadariu, Patriciu
    Sur, Daniel
    Havasi, Andrei
    Vidrean, Andreea
    Muresan, Alexandra
    Piciu, Andra
    Bota, Madalina
    Constantin, Anne-Marie
    Tat, Tiberiu
    Maniu, Dana
    Crisan, Ovidiu
    Cioban, Cosmin Vasile
    Balacescu, Ovidiu
    Coza, Ovidiu
    Balacescu, Loredana
    Marta, Monica Mihaela
    Cainap, Simona
    JOURNAL OF BUON, 2020, 25 (02): : 875 - 883
  • [23] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    Cohen, Steven J.
    Punt, Cornelis J. A.
    Iannotti, Nicholas
    Saidman, Bruce H.
    Sabbath, Kert D.
    Gabrail, Nashat Y.
    Picus, Joel
    Morse, Michael
    Mitchell, Edith
    Miller, M. Craig
    Doyle, Gerald V.
    Tissing, Henk
    Terstappen, Leon W. M. M.
    Meropol, Neal J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3213 - 3221
  • [24] Survival Outcomes With Use of Bevacizumab Beyond Progression (BBP) in Metastatic Colorectal Cancer (MCRC) Patients (Pts)
    Cartwright, T.
    Yu, E.
    Yim, Y.
    Hartnett, H.
    Chung, H.
    Halm, M.
    Forsyth, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S437 - S437
  • [25] Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology
    Cartwright, Thomas H.
    Yim, Yeun Mi
    Yu, Elaine
    Chung, Hsingwen
    Halm, Melissa
    Forsyth, Michael
    CLINICAL COLORECTAL CANCER, 2012, 11 (04) : 238 - 246
  • [26] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [27] Dose-response relationship between light exposure and cycling performance
    Knaier, R.
    Meister, S.
    Aeschbacher, T.
    Gemperle, D.
    Rossmeissl, A.
    Cajochen, C.
    Schmidt-Trucksass, A.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2016, 26 (07) : 794 - 801
  • [28] Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma
    Louvet, C
    de Gramont, A
    Tournigand, C
    Artru, P
    Maindrault-Goebel, F
    Krulik, M
    CANCER, 2001, 91 (11) : 2033 - 2038
  • [29] Association between exposure to bevacizumab beyond first progression (BBP) and overall survival in patients with metastatic colorectal cancer (MCRC): Results from a large observational study (BRiTE)
    Grothey, A.
    Sugrue, M.
    Hedrick, E.
    Purdie, D.
    Yi, J.
    Dong, W.
    Kozloff, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII29 - VII30
  • [30] Dose-Response Relationship between Inorganic Arsenic Exposure and Lung Cancer among Arseniasis Residents with Low Methylation Capacity
    Hsu, Kuang-Hung
    Tsui, Ke-Hung
    Hsu, Ling-I
    Chiou, Hung-Yi
    Chen, Chien-Jen
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05) : 756 - 761
12345